Abstract

e15617Background: Hepatocellular carcinoma (HCC) is sixth most common cancer worldwide. Prognosis following trans arterial (chemo) embolization (TAE/TACE) for HCC remains unclear. The hepatoma arte...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Chemoembolization and Radioembolization for Hepatocellular Carcinoma
Robert J Lewandowski ... Riad Salem
Clinical Gastroenterology and Hepatology | VOL. 11
Robert J Lewandowski, et. al.Robert J Lewandowski ... Riad Salem
25 Jan 2013
Transarterial Radioembolization for Hepatocellular Carcinoma: Who, When… and Y(90)?
Neil Mehta ... Francis Y Yao
Gastroenterology | VOL. 151
Neil Mehta, et. al.Neil Mehta ... Francis Y Yao
27 Oct 2016
Quality Improvement Guidelines for Transhepatic Arterial Chemoembolization, Embolization, and Chemotherapeutic Infusion for Hepatic Malignancy
Constantinos T Sofocleous ... Anne M Covey
Journal of Vascular and Interventional Radiology | VOL. 23
Constantinos T Sofocleous, et. al.Constantinos T Sofocleous ... Anne M Covey
28 Jan 2012
Combined Transarterial Chemoembolization and Percutaneous Radiofrequency Ablation: More Promising Evidence of Effectiveness in Treating Solitary, Medium-Sized Hepatocellular Carcinoma.
Ron C Gaba ... Ketan Y Shah
Journal of vascular and interventional radiology : JVIR | VOL. 30
Ron C Gaba, et. al.Ron C Gaba ... Ketan Y Shah
01 Oct 2019
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes
Cristina Astrid Tentori ... Fabio Ciceri
Journal of Clinical Oncology | VOL. -
Cristina Astrid Tentori, et. al.Cristina Astrid Tentori ... Fabio Ciceri
09 May 2024
Addressing Disability in Cancer Survivors
Rachelle Brick ... Emily S Tonorezos
Journal of Clinical Oncology | VOL. -
Rachelle Brick, et. al.Rachelle Brick ... Emily S Tonorezos
09 May 2024
First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study
Susanna Hegewisch-Becker ... Niall C Tebbutt
Journal of Clinical Oncology | VOL. -
Susanna Hegewisch-Becker, et. al.Susanna Hegewisch-Becker ... Niall C Tebbutt
09 May 2024
A pivotal phase 2 single-arm study of glecirasib (JAB-21822) in patients with NSCLC harboring KRAS G12C mutation.
Yuankai Shi ... Zhengbo Song
Journal of Clinical Oncology | VOL. 42
Yuankai Shi, et. al.Yuankai Shi ... Zhengbo Song
30 Apr 2024
View more papers